The pharmaceutical company Ariad raised the price of a leukemia drug multiple times during a four-year period even as reports of serious cardiovascular side effects mounted.
Read more on NPR
Copyright 2014 All Rights Reserved / Privacy Policy / Sitemap / Contact Us
Edited by / loobobilly / Powered by / M.S.Aditya